213 related articles for article (PubMed ID: 17108893)
1. Reverse dosimetry: interpreting trihalomethanes biomonitoring data using physiologically based pharmacokinetic modeling.
Tan YM; Liao KH; Clewell HJ
J Expo Sci Environ Epidemiol; 2007 Nov; 17(7):591-603. PubMed ID: 17108893
[TBL] [Abstract][Full Text] [Related]
2. Use of a physiologically based pharmacokinetic model to identify exposures consistent with human biomonitoring data for chloroform.
Tan YM; Liao KH; Conolly RB; Blount BC; Mason AM; Clewell HJ
J Toxicol Environ Health A; 2006 Sep; 69(18):1727-56. PubMed ID: 16864423
[TBL] [Abstract][Full Text] [Related]
3. Development of a screening approach to interpret human biomonitoring data on volatile organic compounds: reverse dosimetry on biomonitoring data for trichloroethylene.
Liao KH; Tan YM; Clewell HJ
Risk Anal; 2007 Oct; 27(5):1223-36. PubMed ID: 18076492
[TBL] [Abstract][Full Text] [Related]
4. Computational toxicology of chloroform: reverse dosimetry using Bayesian inference, Markov chain Monte Carlo simulation, and human biomonitoring data.
Lyons MA; Yang RS; Mayeno AN; Reisfeld B
Environ Health Perspect; 2008 Aug; 116(8):1040-6. PubMed ID: 18709138
[TBL] [Abstract][Full Text] [Related]
5. Biomonitoring Equivalents (BE) dossier for trihalomethanes.
Aylward LL; LaKind JS; Hays SM
Regul Toxicol Pharmacol; 2008 Aug; 51(3 Suppl):S68-77. PubMed ID: 18579267
[TBL] [Abstract][Full Text] [Related]
6. Reverse dosimetry modeling of toluene exposure concentrations based on biomonitoring levels from the Canadian health measures survey.
Tohon H; Nong A; Moreau M; Valcke M; Haddad S
J Toxicol Environ Health A; 2018; 81(20):1066-1082. PubMed ID: 30365389
[TBL] [Abstract][Full Text] [Related]
7. Health risk assessment of trihalomethanes mixtures from daily water-related activities via multi-pathway exposure based on PBPK model.
Zhang Y; Zhang N; Niu Z
Ecotoxicol Environ Saf; 2018 Nov; 163():427-435. PubMed ID: 30075445
[TBL] [Abstract][Full Text] [Related]
8. Using physiologically based pharmacokinetic models to estimate the health risk of mixtures of trihalomethanes from reclaimed water.
Niu Z; Zang X; Zhang Y
J Hazard Mater; 2015 Mar; 285():190-8. PubMed ID: 25497033
[TBL] [Abstract][Full Text] [Related]
9. Reconstructing exposures from biomarkers using exposure-pharmacokinetic modeling--A case study with carbaryl.
Brown K; Phillips M; Grulke C; Yoon M; Young B; McDougall R; Leonard J; Lu J; Lefew W; Tan YM
Regul Toxicol Pharmacol; 2015 Dec; 73(3):689-98. PubMed ID: 26545325
[TBL] [Abstract][Full Text] [Related]
10. Estimation of interindividual pharmacokinetic variability factor for inhaled volatile organic chemicals using a probability-bounds approach.
Nong A; Krishnan K
Regul Toxicol Pharmacol; 2007 Jun; 48(1):93-101. PubMed ID: 17367907
[TBL] [Abstract][Full Text] [Related]
11. Variability in biological exposure indices using physiologically based pharmacokinetic modeling and Monte Carlo simulation.
Thomas RS; Bigelow PL; Keefe TJ; Yang RS
Am Ind Hyg Assoc J; 1996 Jan; 57(1):23-32. PubMed ID: 8588550
[TBL] [Abstract][Full Text] [Related]
12. Estimation of toluene exposure in air from BMA (S-benzylmercapturic acid) urinary measures using a reverse dosimetry approach based on physiologically pharmacokinetic modeling.
Tohon H; Valcke M; Aranda-Rodriguez R; Nong A; Haddad S
Regul Toxicol Pharmacol; 2021 Mar; 120():104860. PubMed ID: 33406392
[TBL] [Abstract][Full Text] [Related]
13. The utility of PBPK in the safety assessment of chloroform and carbon tetrachloride.
Delic JI; Lilly PD; MacDonald AJ; Loizou GD
Regul Toxicol Pharmacol; 2000 Oct; 32(2):144-55. PubMed ID: 11067771
[TBL] [Abstract][Full Text] [Related]
14. Use of Markov Chain Monte Carlo analysis with a physiologically-based pharmacokinetic model of methylmercury to estimate exposures in US women of childbearing age.
Allen BC; Hack CE; Clewell HJ
Risk Anal; 2007 Aug; 27(4):947-59. PubMed ID: 17958503
[TBL] [Abstract][Full Text] [Related]
15. Application of an updated physiologically based pharmacokinetic model for chloroform to evaluate CYP2E1-mediated renal toxicity in rats and mice.
Sasso AF; Schlosser PM; Kedderis GL; Genter MB; Snawder JE; Li Z; Rieth S; Lipscomb JC
Toxicol Sci; 2013 Feb; 131(2):360-74. PubMed ID: 23143927
[TBL] [Abstract][Full Text] [Related]
16. Uncertainty and variability in the exposure reconstruction of chemical incidents--the case of acrylonitrile.
Huizer D; Ragas AM; Oldenkamp R; van Rooij JG; Huijbregts MA
Toxicol Lett; 2014 Dec; 231(3):337-43. PubMed ID: 25050995
[TBL] [Abstract][Full Text] [Related]
17. Quantitative interpretation of human biomonitoring data.
Clewell HJ; Tan YM; Campbell JL; Andersen ME
Toxicol Appl Pharmacol; 2008 Aug; 231(1):122-33. PubMed ID: 18589468
[TBL] [Abstract][Full Text] [Related]
18. Reconstruction of Exposure to m-Xylene from Human Biomonitoring Data Using PBPK Modelling, Bayesian Inference, and Markov Chain Monte Carlo Simulation.
McNally K; Cotton R; Cocker J; Jones K; Bartels M; Rick D; Price P; Loizou G
J Toxicol; 2012; 2012():760281. PubMed ID: 22719759
[TBL] [Abstract][Full Text] [Related]
19. Evaluation and modeling of the impact of coexposures to VOC mixtures on urinary biomarkers.
Marchand A; Aranda-Rodriguez R; Tardif R; Nong A; Haddad S
Inhal Toxicol; 2016; 28(6):260-73. PubMed ID: 27053005
[TBL] [Abstract][Full Text] [Related]
20. Development of PK- and PBPK-based modeling tools for derivation of biomonitoring guidance values.
Bartels M; Rick D; Lowe E; Loizou G; Price P; Spendiff M; Arnold S; Cocker J; Ball N
Comput Methods Programs Biomed; 2012 Nov; 108(2):773-88. PubMed ID: 22704290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
